表紙
市場調查報告書

醫療部門金屬&金屬氧化物奈米粒子的市場分析·預測:類型 (黃金·銀·氧化鐵·氧化鋁·氧化釓·鈰)·用途 (in-vivo成像·標的藥物輸送·質子治療·in-vitro化驗) 別

Nanoparticles - Metal & Metal Oxides Market In Healthcare By Type (Gold, Silver, Iron Oxide, Alumina, Gadolinium, Cerium), By Application (In-vivo Imaging, Targeted Drug Delivery, Proton Therapy, In-vitro assays), & Segment Forecasts, 2013 - 2025

出版商 Grand View Research, Inc. 商品編碼 502229
出版日期 內容資訊 英文 142 Pages
商品交期: 2-3個工作天內
價格
Back to Top
醫療部門金屬&金屬氧化物奈米粒子的市場分析·預測:類型 (黃金·銀·氧化鐵·氧化鋁·氧化釓·鈰)·用途 (in-vivo成像·標的藥物輸送·質子治療·in-vitro化驗) 別 Nanoparticles - Metal & Metal Oxides Market In Healthcare By Type (Gold, Silver, Iron Oxide, Alumina, Gadolinium, Cerium), By Application (In-vivo Imaging, Targeted Drug Delivery, Proton Therapy, In-vitro assays), & Segment Forecasts, 2013 - 2025
出版日期: 2017年04月21日內容資訊: 英文 142 Pages
簡介

本報告提供全球醫療部門金屬·金屬氧化物奈米粒子的市場調查,提供市場定義和概要,市場促進因素·抑制因素分析,普及·成長預測的製圖,SWOT分析,類型·用途·地區/各主要國家趨勢與市場規模的變化與預測,競爭環境,並彙整主要企業的簡介等資訊。

第1章 調查手法

第2章 摘要整理

  • 市場概要

第3章 市場可變因素·趨勢·展望

  • 市場區隔·展望
    • 成長推進因素分析
    • 阻礙成長要素分析
  • 普及·成長預測製圖
  • SWOT分析
  • 波特的產業分析
  • 開發平台分析

第4章 市場估計·趨勢分析:各類型

  • 趨勢分析:各類型
  • 黃金奈米粒子
    • 市場變化與預測
  • 銀奈米粒子
    • 市場變化與預測
  • 氧化鐵奈米粒子
    • 市場變化與預測
  • 氧化鋁奈米粒子
    • 市場變化與預測
  • 氧化釓奈米粒子
    • 市場變化與預測
  • 其他
    • 市場變化與預測

第5章 市場估計·趨勢分析:各用途

  • 趨勢分析:各用途
  • in-vivo成像
    • 市場變化與預測
  • 標的藥物輸送
    • 市場變化與預測
  • 質子治療
    • 市場變化與預測
  • in-vitro化驗
    • 市場變化與預測
  • 細胞·Phantom成像
    • 市場變化與預測

第6章 市場估計·趨勢分析:各地區

  • 市場佔有率實際成果·預測:各地區
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
  • 亞太地區
    • 日本
    • 中國
  • 南美
    • 巴西
  • 中東·非洲
    • 南非

第7章 競爭環境

  • 策略性架構
  • 打入市場類別
  • 企業簡介
目錄
Product Code: GVR-1-68038-805-3

The global nanoparticles - metal & metal oxides market in healthcare is anticipated to reach USD 80.74 billion by 2025, according to a new report by Grand View Research, Inc. Several nanotechnologies based medicines have been put forward for approval by the FDA which is anticipated to propel growth.

Success of nanomedicine has prompted the development of enhanced nanomaterials for clinical applications with particular emphasis in therapy and diagnostics. This has resulted into the significant production of metal oxide particles that hold potential utility in human medicine.

Remarkable evolution has been made in nanoparticle based medicines for theranostic applications in disease management. Diverse metals have been used for development of medicines with a promise to optimize the efficacy of nanomedicines and to improve the current standard of medical and clinical practices.

These particles are recognized to have major applications in drug delivery, diagnostic products, biomarker discovery, and product packaging. Widespread application spectrum of these particles in maintaining human health is expected to dramatically impact the progress of this market in the coming years.

Moreover, metal oxides are observed to have significant role in cancer treatment. Nanoparticle-augmented systems enable high-concentration targeted drug delivery to cancer cells, which in turn, is expected to enhance the usage rate of metal nanoparticles for cancer treatment. Development of drug delivery strategies using nanoparticle approaches are expected to bring about changes effective for cancer treatment.

However, prolonged exposure of nanoparticles adversely affects the human health as well environment thereby restraining their adoption rate. These products are involved in autophagy, oxidative stress, lysosome dysfunction, and the activation of certain signaling pathways, thereby exhibiting toxicity for human health.

Further key findings from the report suggest:

Presence of untapped potential in alumina and alumina oxide particles is anticipated to create immense opportunities

Aluminum oxide in combination with polymeric membranes is studied for enhancement of drug delivery owing to its high porosity property displayed in the membranes

This enhanced efficacy of the membrane performance by the addition of alumina nanoparticles to polymeric membranes is projected to increase its adoption

Approval of various nanoparticle composition and surface properties for clinical diagnostics and treatment of viral infections is anticipated drive market demand

In-vivo imaging dominated the market with respect to revenue share

Use of antibody conjugated to Au nanorods Raman spectrum with polarized, sharpened, and enhanced results can be attributed for larger revenue share

Oncology dominated over a decade and is projected to sustain its share over the forecast period.

Rising incidence of cancer and other chronic multi-drug resistant diseases pronounces the demand for these particles.

Aforementioned factor is anticipated to drive targeted delivery with fastest YoY growth

Asia Pacific is projected to showcase lucrative progress in the coming years

Key countries in the region are working to enhance the patient's reach to nanotechnology-based solutions

Moreover, continuous support from the government bodies pertaining to initiation of new projects is expected to play crucial role for projected CAGR

Key players contributing in this market are Pfizer Inc., Brigham Women's Hospital (BWH), Immunolight LLC, nanoComposix, Nanobiotix, Nanospectra Biosciences, Inc, Merck KGaA, and AstraZeneca

These participants are investing in development of the product portfolio that can target the chronic disorders

Arrowhead Pharmaceuticals, Cytimmune Sciences, Inc, Nanobiotix, Celgene Corporation, Siteman Center of Cancer Nanotechnology Excellence (Washington University CCNE), and BIND Biosciences are few companies that have products in the pipeline phase

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Information Procurement
  • 1.2 Data Analysis

Chapter 2 Executive Summary

  • 2.1 Market Snapshot

Chapter 3 Nanoparticles - Metal & Metal Oxides Market Variables, Trends& Scope

  • 3.1 Market segmentation & scope
    • 3.1.1 Market Driver Analysis
      • 3.1.1.1 Substantial number of nanoparticle-based therapeutics and pharmaceuticals in R&D
      • 3.1.1.2 Growing utility potential of metal nanoparticles in cancer and other diseases treatment
      • 3.1.1.3 Rapid advances in analytical methods for detection and evaluation of nanoparticles
    • 3.1.2 Market Restraint Analysis
      • 3.1.2.1 Toxicity and environmental risks of metal nanomaterials
      • 3.1.2.2 Regulatory issues pertaining to the use and approval of metal nanoparticles
  • 3.2 Penetration & growth prospect mapping for type of nanoparticles, 2016
  • 3.3 Nanoparticles - Metal & Metal Oxides Market - SWOT Analysis, By Factor (political & legal, economic and technological)
  • 3.4 Industry Analysis - Porter's
  • 3.5 Metal & Metal Oxide Nanoparticles Pipeline Analysis
    • 3.5.1 Arrowhead Pharmaceuticals
    • 3.5.2 Nanobiotix
    • 3.5.3 BIND Biosciences
    • 3.5.4 CELGENE CORPORATION
    • 3.5.5 CYTIMMUNE SCIENCES, INC
    • 3.5.6 Siteman Center of Cancer Nanotechnology Excellence (Washington University CCNE)
    • 3.5.7 Centers of Cancer Nanotechnology Excellence

Chapter 4 Nanoparticles - Metal & Metal Oxides: Type Estimates & Trend Analysis

  • 4.1 Metal & metal oxides nanoparticles in healthcare market: Type movement analysis
  • 4.2 Gold Nanoparticles
    • 4.2.1 Global gold nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
  • 4.3 Silver Nanoparticles
    • 4.3.1 Global silver nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
  • 4.4 Iron Oxide Nanoparticles
    • 4.4.1 Global iron oxide nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
  • 4.5 Alumina Nanoparticles
    • 4.5.1 Global alumina nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
  • 4.6 Gadolinium oxide nanoparticles
    • 4.6.1 Global gadolinium oxide nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
  • 4.7 Others
    • 4.7.1 Global other metal nanoparticles market in healthcare, 2013 - 2025 (USD Billion)

Chapter 5 Nanoparticles - Metal & Metal Oxides: Application Estimates & Trend Analysis

  • 5.1 Metal & metal oxides nanoparticles in healthcare market: Application movement analysis
  • 5.2 In-vivo Imaging
    • 5.2.1 Global in-vivo imaging market, 2013 - 2025 (USD Billion)
  • 5.3 Targeted Drug Delivery
    • 5.3.1 Global targeted drug delivery market, 2013 - 2025 (USD Billion)
  • 5.4 Proton Therapy
    • 5.4.1 Global proton therapy market, 2013 - 2025 (USD Billion)
  • 5.5 In-vitro Assays
    • 5.5.1 Global in-vitro assays market, 2013 - 2025 (USD Billion)
  • 5.6 Cell & Phantom Imaging
    • 5.6.1 Global cell & phantom imaging market, 2013 - 2025 (USD Billion)

Chapter 6 Nanoparticles - Metal & Metal Oxides: Regional Estimates & Trend Analysis, by Type& Application

  • 6.1 Metal & metal oxides nanoparticles in healthcare market share by region, 2016 & 2025
  • 6.2 North America
    • 6.2.1 Metal & metal oxides nanoparticles in healthcare market, 2013 - 2025 (USD Billion)
    • 6.2.2 U.S.
      • 6.2.2.1 Metal & metal oxides nanoparticles in healthcare market, by type, 2013 - 2025 (USD Billion)
      • 6.2.2.2 Metal & metal oxides nanoparticles in healthcare market, by application, 2013 - 2025 (USD Billion)
    • 6.2.3 Canada
      • 6.2.3.1 Metal & metal oxides nanoparticles in healthcare market, by type, 2013 - 2025 (USD Billion)
      • 6.2.3.2 Metal & metal oxides nanoparticles in healthcare market, by application, 2013 - 2025 (USD Billion)
  • 6.3 Europe
    • 6.3.1 Metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
    • 6.3.2 Germany
      • 6.3.2.1 Metal & metal oxides nanoparticles in healthcare market, by type, 2013 - 2025 (USD Billion)
      • 6.3.2.2 Metal & metal oxides nanoparticles in healthcare market, by application, 2013 - 2025 (USD Billion)
    • 6.3.3 UK
      • 6.3.3.1 Metal & metal oxides nanoparticles in healthcare market, by type, 2013 - 2025 (USD Billion)
      • 6.3.3.2 Metal & metal oxides nanoparticles in healthcare market, by application, 2013 - 2025 (USD Billion)
  • 6.4 Asia Pacific
    • 6.4.1 Metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
    • 6.4.2 Japan
      • 6.4.2.1 Metal & metal oxides nanoparticles in healthcare market, by type, 2013 - 2025 (USD Billion)
      • 6.4.2.2 Metal & metal oxides nanoparticles in healthcare market, by application, 2013 - 2025 (USD Billion)
    • 6.4.3 China
      • 6.4.3.1 Metal & metal oxides nanoparticles in healthcare market, by type, 2013 - 2025 (USD Billion)
      • 6.4.3.2 Metal & metal oxides nanoparticles in healthcare market, by application, 2013 - 2025 (USD Billion)
  • 6.5 Latin America
    • 6.5.1 Metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
    • 6.5.2 Brazil
      • 6.5.2.1 Metal & metal oxides nanoparticles in healthcare market, by type, 2013 - 2025 (USD Billion)
      • 6.5.2.2 Metal & metal oxides nanoparticles in healthcare market, by application, 2013 - 2025 (USD Billion)
  • 6.6 Middle East & Africa
    • 6.6.1 Metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
    • 6.6.2 South Africa
      • 6.6.2.1 Metal & metal oxides nanoparticles in healthcare market, by type, 2013 - 2025 (USD Billion)
      • 6.6.2.2 Metal & metal oxides nanoparticles in healthcare market, by application, 2013 - 2025 (USD Billion)

Chapter 7 Competitive Landscape

  • 7.1 Strategy framework
  • 7.2 Market participation categorization
  • 7.3 Company Profiles
    • 7.3.1 Immunolight LLC
      • 7.3.1.1 Company overview
      • 7.3.1.2 Financial performance
      • 7.3.1.3 Product benchmarking
    • 7.3.2 Merck KGaA
      • 7.3.2.1 Company overview
      • 7.3.2.1.1 Sigma-Aldrich Co. LLC
      • 7.3.2.2 Financial performance
      • 7.3.2.2.1 Financial performance
      • 7.3.2.3 Product benchmarking
      • 7.3.2.4 Strategic initiatives
    • 7.3.3 CYTIMMUNE SCIENCES, INC.
      • 7.3.3.1 Company overview
      • 7.3.3.2 Financial performance
      • 7.3.3.3 Product benchmarking
      • 7.3.3.4 Strategic initiatives
    • 7.3.4 CELGENE CORPORATION
      • 7.3.4.1 Company overview
      • 7.3.4.1.1 Abraxis BioScience, Inc.
      • 7.3.4.2 Financial performance
      • 7.3.4.3 Product benchmarking
      • 7.3.4.4 Strategic initiatives
    • 7.3.5 AstraZeneca
      • 7.3.5.1 Company overview
      • 7.3.5.2 Financial performance
      • 7.3.5.3 Product benchmarking
      • 7.3.5.4 Strategic initiatives
    • 7.3.6 Brigham and Women's Hospital (BWH)
      • 7.3.6.1 Company overview
      • 7.3.6.1 Financial performance
      • 7.3.6.2 Product benchmarking
    • 7.3.7 Nanoprobes, Inc.
      • 7.3.7.1 Company overview
      • 7.3.7.2 Financial performance
      • 7.3.7.3 Product benchmarking
    • 7.3.8 Z-MEDICA
      • 7.3.8.1 Company overview
      • 7.3.8.2 Financial performance
      • 7.3.8.3 Product benchmarking
    • 7.3.9 Nanospectra Biosciences, Inc.
      • 7.3.9.1 Company overview
      • 7.3.9.2 Financial performance
      • 7.3.9.3 Product benchmarking
      • 7.3.9.4 Strategic initiatives
    • 7.3.10 Nanobiotix
      • 7.3.10.1 Company overview
      • 7.3.10.2 Financial performance
      • 7.3.10.3 Product benchmarking
      • 7.3.10.4 Strategic initiatives
    • 7.3.11 Oxonica
      • 7.3.11.1 Company overview
      • 7.3.11.1.1 Nanoplex Technologies, Inc.
      • 7.3.11.2 Financial performance
      • 7.3.11.3 Product benchmarking
    • 7.3.12 Pfizer Inc.
      • 7.3.12.1 Company overview
      • 7.3.12.1.1 BIND Therapeutics
      • 7.3.12.2 Financial performance
      • 7.3.12.3 Product benchmarking
      • 7.3.12.4 Strategic initiatives
    • 7.3.13 nanoComposix
      • 7.3.13.1 Company overview
      • 7.3.13.2 Financial performance
      • 7.3.13.3 Product benchmarking

List of Tables

  • TABLE 1 Clinical studies for metal nanoparticles based therapeutic solutions in 2015
  • TABLE 2 Search results of the U.S. databases using the term "nanoparticle" in combination with other terms
  • TABLE 3 Metal and metal oxide nanoparticles and cancer research
  • TABLE 4 In vitro/in vivo studies on toxicity of various types of metal nanoparticles
  • TABLE 5 Gold nanoparticles and their applications
  • TABLE 6 Role of superparamagnetic iron oxide nanoparticles in different areas of Magnetic Resonance Imaging (MRI)
  • TABLE 7 Active cancer-targeting strategies of magnetic nanoparticle
  • TABLE 8 North America metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
  • TABLE 9 North America metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
  • TABLE 10 North America metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
  • TABLE 11 North America metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
  • TABLE 12 Patent applicant for nanotechnology based therapeutics
  • TABLE 13 U.S. metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
  • TABLE 14 U.S. metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
  • TABLE 15 U.S. metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
  • TABLE 16 U.S. metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
  • TABLE 17 Nanotechnology organizations which are involved in publishing nanoscience based articles
  • TABLE 18 Canada metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
  • TABLE 19 Canada metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
  • TABLE 20 Canada metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
  • TABLE 21 Canada metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
  • TABLE 22 Europe metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
  • TABLE 23 Europe metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
  • TABLE 24 Europe metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
  • TABLE 25 Europe metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
  • TABLE 26 Germany metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
  • TABLE 27 Germany metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
  • TABLE 28 Germany metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
  • TABLE 29 Germany metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
  • TABLE 30 UK metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
  • TABLE 31 UK metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
  • TABLE 32 UK metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
  • TABLE 33 UK metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
  • TABLE 34 Asia Pacific metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
  • TABLE 35 Asia Pacific metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
  • TABLE 36 Asia Pacific metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
  • TABLE 37 Asia Pacific metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
  • TABLE 38 Japan metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
  • TABLE 39 Japan metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
  • TABLE 40 Japan metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
  • TABLE 41 Japan metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
  • TABLE 42 China metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
  • TABLE 43 China metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
  • TABLE 44 China metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
  • TABLE 45 China metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
  • TABLE 46 Latin America metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
  • TABLE 47 Latin America metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
  • TABLE 48 Latin America metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
  • TABLE 49 Latin America metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
  • TABLE 50 Brazil metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
  • TABLE 51 Brazil metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
  • TABLE 52 Brazil metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
  • TABLE 53 Brazil metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
  • TABLE 54 MEA metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
  • TABLE 55 MEA metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
  • TABLE 56 MEA metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
  • TABLE 57 MEA metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
  • TABLE 58 South Africa metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
  • TABLE 59 South Africa metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
  • TABLE 60 South Africa metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
  • TABLE 61 South Africa metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain based sizing & forecasting
  • FIG. 6 QFD modelling for market share assessment
  • FIG. 7 Market summary
  • FIG. 8 Market trends & outlook
  • FIG. 9 Market segmentation & scope
  • FIG. 10 Market driver relevance analysis (Current & future impact)
  • FIG. 11 Market restraint relevance analysis (Current & future impact)
  • FIG. 12 Penetration & growth prospect mapping for type of nanoparticles, 2016
  • FIG. 13 SWOT Analysis, By Factor (political & legal, economic and technological)
  • FIG. 14 Porter's Five Forces Analysis
  • FIG. 15 Metal & metal oxides nanoparticles in healthcare market type outlook key takeaways
  • FIG. 16 Metal & metal oxides nanoparticles in healthcare market: Type movement analysis
  • FIG. 17 Global gold nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
  • FIG. 18 Global silver nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
  • FIG. 19 Global iron oxide nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
  • FIG. 20 Global alumina nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
  • FIG. 21 Global gadolinium oxide nanoparticles market, 2013 - 2025 (USD Billion)
  • FIG. 22 Global other metal nanoparticles market, 2013 - 2025 (USD Billion)
  • FIG. 23 Metal & metal oxides nanoparticles in healthcare market: Application outlook key takeaways
  • FIG. 24 Global metal & metal oxides nanoparticles in healthcare: Application movement analysis
  • FIG. 25 Global in-vivo imaging market, 2013 - 2025 (USD Billion)
  • FIG. 26 Global targeted drug delivery market, 2013 - 2025 (USD Billion)
  • FIG. 27 Global proton therapy market, 2013 - 2025 (USD Billion)
  • FIG. 28 Global in-vitro assays market, 2013 - 2025 (USD Billion)
  • FIG. 29 Global cell & phantom imaging market, 2013 - 2025 (USD Billion)
  • FIG. 30 Regional market place: Key takeaway
  • FIG. 31 Metal & metal oxides nanoparticles in healthcare regional outlook, 2016 & 2025
  • FIG. 32 North America metal & metal oxides nanoparticles in healthcare market, 2013 - 2025 (USD Billion)
  • FIG. 33 U.S. metal & metal oxides nanoparticles in healthcare market, 2013 - 2025 (USD Billion)
  • FIG. 34 Canada. metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
  • FIG. 35 Europe metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
  • FIG. 36 Germany metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
  • FIG. 37 UK metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
  • FIG. 38 Asia Pacific metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
  • FIG. 39 Japan metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
  • FIG. 40 China metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
  • FIG. 41 Latin America metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
  • FIG. 42 Brazil metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
  • FIG. 43 Middle East & Africa metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
  • FIG. 44 South Africa metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
  • FIG. 45 Strategy framework
  • FIG. 46 Participant categorization
Back to Top